Balance Sheet Data

Kazia Therapeutics Limited (KZIA)

$0.9952

-0.01 (-1.47%)

Year
A/P
2019
Actual
2020
Actual
2021
Actual
2022
Actual
2023
Actual
2024
Projected
2025
Projected
2026
Projected
2027
Projected
2028
Projected
Total Cash 5.438.7627.597.365.2434,843,747.29166,213,533,993.18792,880,818,741,887.883,782,243,103,949,726,7201.8,042,261,282,186,712e+22
Total Cash (%)
Account Receivables 1.551.190.080.050.11475,183.182,266,744,573.7410,812,947,961,163.9351,580,511,084,091,536246,052,152,775,708,278,784
Account Receivables (%)
Inventories ----------
Inventories (%)
Accounts Payable 1.051.691.891.520.867,195,975.7234,326,633,842.72163,746,771,348,864.25781,113,733,727,350,2723.726,111,116,521,345e+21
Accounts Payable (%)
Capital Expenditure ----------
Capital Expenditure (%)



To support growth, companies need to keep investing in capital items – including property, plants and equipment.
To calculate this net investment,we take capital expenditure (found in the company’s statement of cash flows) and subtract non-cash depreciation (found on the income statement).
Working capital refers to the cash a company needs for day-to-day operations.
The faster a company expands, the more cash it will need.
To calculate working capital, we take current assets and subtract current liabilities.
You can find both of these on a company’s balance sheet, which is published in its quarterly and annual financial statements.